Apyx Medical CorporationAPYXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+30.0%
5Y CAGR+27.1%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+30.0%/yr
vs +27.1%/yr prior
5Y CAGR
+27.1%/yr
Consistent
Acceleration
+2.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3.3x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$33.81M+80.4%
2024$18.74M+0.8%
2023$18.59M+20.9%
2022$15.38M+3.1%
2021$14.92M+46.1%
2020$10.21M+11.7%
2019$9.14M+55.1%
2018$5.89M-69.2%
2017$19.12M+2.2%
2016$18.71M-